CD166 expression is not correlated with gender, tumor location, distant metastasis, lymph node status, clinical stage, T classification, tumor differentiation, or the prognosis of CRC patients in OS and PFS using multivariate regression analysis. Here, ALCAM is linked to neoplasm.